Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Novogen Regains Full Compliance with NASDAQ Listing Rule 2015-04-28 11:48
Novogen Posts Details on Rights Issue Offering for Shareholders 2015-04-27 12:15
Cantrixil Receives Orphan Drug Designation from FDA 2015-04-22 12:29
Novogen Conducts Private Placement and Announces Rights Offering to Shareholders 2015-04-21 11:34
Cantrixil Highly Successful in Preventing Growth of Chemo-Resistant Ovarian Cancer 2015-04-21 08:52
Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 2015-04-17 09:43
Australian Studies Confirm Anisina as Potential Important New Weapon Against Melanoma 2015-04-09 11:06
Novogen Engages Leading US Investor Relations Firm 2015-04-02 10:49
Yale University and Novogen Release Data on Cantrixil Mode of Action 2015-03-30 08:53
Potential of Anisina to Become Major New Chemotherapy Confirmed by Coda Study 2015-03-19 04:00
Sky News, Helen Dalley interviews Dr Graham Kelly 2015-03-10 12:28
Novogen to Present at AusBiotech "Broker Meets Biotech" Event 2015-03-03 11:02
ABC TV Interview Discusses the Potential of Trilexium(TM) to Treat Brain Cancer 2014-09-29 19:09
1 2 3